Markets
S&P 500$7,175.83-2.00%|Dow Jones$49,097.06-2.18%|Nasdaq Composite$23,879.2-2.24%|FTSE 100£10,452.68-0.97%|DAX€25,463.81-1.13%|CAC 40€8,080.74-0.84%|Nikkei 225¥59,444.21+0.47%|Shanghai Composite$3,577.62-0.28%|Hang Seng$22,841.62-1.95%|MSCI World$193.91-1.93%|Apple$349.21-1.31%|Microsoft$498.3-2.48%|NVIDIA$145.98-3.87%|Alphabet$272.66-4.46%|Amazon$257.37-4.59%|Meta$596.22-3.73%|Tesla$374.41-2.72%|SpaceX$138.43-4.27%|LVMH€391.9+1.28%|Hermès€1,272-0.97%|Berkshire$572.04-0.35%|JPMorgan$320.22-1.47%|Barclays$410.95+0.11%|GBP / USD1.3087-0.45%|GBP / EUR1.1926-0.43%|GBP / JPY209.0020-0.26%|GBP / CHF1.1048-0.37%|GBP / CAD1.8774-0.33%|GBP / AUD1.9661+0.40%|GBP / NZD2.3876-0.32%|GBP / AED4.8066-0.43%|US Dollar Index (DXY)103.9150+0.00%|AUD / USD0.6658-0.87%|NZD / USD0.5482-0.13%|USD / EUR0.9115+0.03%|USD / JPY159.7050+0.19%|USD / CHF0.8442+0.08%|USD / CAD1.4348+0.12%|USD / CNY6.6665+0.13%|USD / INR93.2900-0.18%|USD / SGD1.2921+0.22%|USD / HKD7.8417-0.04%|USD / SEK10.1983+0.28%|USD / NOK9.7704+0.81%|USD / MXN19.0860+1.24%|USD / ZAR17.5019+1.34%|USD / TRY50.4556-0.01%|EUR / USD1.0971-0.03%|EUR / GBP0.8381+0.43%|EUR / JPY175.1770+0.16%|EUR / CHF0.9260+0.06%|EUR / CAD1.5734+0.09%|EUR / AUD1.6478+0.82%|Bitcoin$61,603-2.19%|Ethereum$1,746-1.58%|Tether$1.00+0.02%|Binance Coin$577-0.82%|Solana$72.53-1.39%|XRP$0.96-0.94%|Cardano$0.15-0.42%|USD Coin$1.00+0.00%|TRON$0.31+0.11%|Dogecoin$0.06-1.69%|S&P 500$7,175.83-2.00%|Dow Jones$49,097.06-2.18%|Nasdaq Composite$23,879.2-2.24%|FTSE 100£10,452.68-0.97%|DAX€25,463.81-1.13%|CAC 40€8,080.74-0.84%|Nikkei 225¥59,444.21+0.47%|Shanghai Composite$3,577.62-0.28%|Hang Seng$22,841.62-1.95%|MSCI World$193.91-1.93%|Apple$349.21-1.31%|Microsoft$498.3-2.48%|NVIDIA$145.98-3.87%|Alphabet$272.66-4.46%|Amazon$257.37-4.59%|Meta$596.22-3.73%|Tesla$374.41-2.72%|SpaceX$138.43-4.27%|LVMH€391.9+1.28%|Hermès€1,272-0.97%|Berkshire$572.04-0.35%|JPMorgan$320.22-1.47%|Barclays$410.95+0.11%|GBP / USD1.3087-0.45%|GBP / EUR1.1926-0.43%|GBP / JPY209.0020-0.26%|GBP / CHF1.1048-0.37%|GBP / CAD1.8774-0.33%|GBP / AUD1.9661+0.40%|GBP / NZD2.3876-0.32%|GBP / AED4.8066-0.43%|US Dollar Index (DXY)103.9150+0.00%|AUD / USD0.6658-0.87%|NZD / USD0.5482-0.13%|USD / EUR0.9115+0.03%|USD / JPY159.7050+0.19%|USD / CHF0.8442+0.08%|USD / CAD1.4348+0.12%|USD / CNY6.6665+0.13%|USD / INR93.2900-0.18%|USD / SGD1.2921+0.22%|USD / HKD7.8417-0.04%|USD / SEK10.1983+0.28%|USD / NOK9.7704+0.81%|USD / MXN19.0860+1.24%|USD / ZAR17.5019+1.34%|USD / TRY50.4556-0.01%|EUR / USD1.0971-0.03%|EUR / GBP0.8381+0.43%|EUR / JPY175.1770+0.16%|EUR / CHF0.9260+0.06%|EUR / CAD1.5734+0.09%|EUR / AUD1.6478+0.82%|Bitcoin$61,603-2.19%|Ethereum$1,746-1.58%|Tether$1.00+0.02%|Binance Coin$577-0.82%|Solana$72.53-1.39%|XRP$0.96-0.94%|Cardano$0.15-0.42%|USD Coin$1.00+0.00%|TRON$0.31+0.11%|Dogecoin$0.06-1.69%|
Health

DoNotAge launches Black Friday offers with £18,800 lifetime supplement membership

DoNotAge launches £18,800 lifetime supplement membership claiming £40,870 savings over 30 years, alongside Black Friday discounts up to 40 per cent on longevity products.

19 November 2026·5 min read
DoNotAge launches Black Friday offers with £18,800 lifetime supplement membership

The British longevity supplement company has introduced discounts of up to 40 per cent throughout November, alongside a lifetime membership that it claims could save customers more than £40,000 over 30 years.

Health and longevity supplement company DoNotAge.org has launched its 2026 Black Friday offers, including discounted wellness bundles, complimentary products and a lifetime membership costing £18,800.

The promotion, which runs throughout November, covers products marketed for sleep, physical performance, recovery and general wellbeing.

With packages starting at £16, the company is targeting both existing supplement users and consumers interested in incorporating nutritional products into their daily routines.

Its most expensive offer is a lifetime subscription designed to eliminate recurring payments for its flagship supplement range.

Lifetime membership promises substantial savings

DoNotAge is offering 100 lifetime memberships at £18,800 each, providing an annual supply of its DoNotAge Routine supplement for the remainder of the customer's life.

The company claims that purchasing the equivalent product through regular four weekly subscriptions over 30 years would cost £59,670, representing a potential saving of £40,870 at current advertised prices.

The membership also includes a complimentary year's supply of DoNotAge Performance.

DoNotAge Routine combines 15 ingredients in a daily drink marketed as supporting long term health.

The company cites human clinical research reporting an average 76 per cent increase in NAD+ levels, alongside improvements in participants' self reported wellbeing.

NAD+ is a molecule involved in cellular energy metabolism, although increases in NAD+ levels do not, by themselves, establish that a supplement extends human lifespan or prevents age related disease.

Discounts on sleep and performance supplements

Among the November offers is the SureSleep bundle, priced at £413 for 12 containers of 180g, representing an advertised saving of £103.

The company markets the product as supporting sleep quality and recovery, citing a 21 day study in which 88 per cent of participants reported improved sleep.

However, the press release does not provide sufficient details about the study's size, design or control group to independently assess those findings.

Customers purchasing DoNotAge Routine subscriptions can also receive complimentary supplies of DoNotAge Performance, a dissolvable supplement containing creatine monohydrate, NAC and the company's Nitralis ingredient.

The offers vary according to subscription length.

A four weekly Routine subscription costs £153 and includes one complimentary Performance pouch with the first order.

An annual subscription costs £1,674 and includes a year's supply of Performance, while the lifetime membership also provides one year of the product at no additional charge.

The company values these complimentary products at between £70 and £840, depending on the subscription selected.

Wellness bundles discounted by up to 40 per cent

DoNotAge has also introduced fixed supplement bundles with advertised discounts ranging from 20 to 40 per cent.

Prices start at £118 for a package containing berberine, probiotics, collagen peptides, omega 3 and apigenin.

The products are marketed for different aspects of wellbeing, including digestive health, skin and joint health, and metabolic function.

Customers can alternatively create their own bundles from a selection of 21 supplements, with prices starting at £16 and advertised discounts of between 5 and 35 per cent.

The company says the flexible options are intended to make its products more accessible to consumers with different budgets and health interests.

Growing interest in longevity products

The promotion reflects the increasing commercial interest in longevity products, as supplement companies seek to attract consumers looking to maintain their health as they age.

However, the scientific evidence supporting individual ingredients varies considerably, and products marketed for longevity should not be assumed to slow biological ageing or extend lifespan.

Supplements can also interact with medicines or be unsuitable for certain people, making professional advice particularly important for those managing existing health conditions.

For consumers considering DoNotAge's lifetime membership, the potential savings also depend on continued product supply, the company's ability to fulfil its long term commitments and whether customers would otherwise maintain the same subscription for decades.

The company's Black Friday offers are scheduled to remain available until the end of November 2026.

Share

Continue Reading

More Health